---
$id: https://graph.org.ai/products/commodity/51263115
$type: Product
source: UNSPSC
code: "51263115"
title: "Bupranolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bupranolol

**UNSPSC Code**: 51263115
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H22ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 858YGI5PIT, chemically known as 2-propanol, 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)- (8ci) but generally known as bupranolol, which bears US NIH Compound Identifier 2475. Bupranolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bupranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05984MIG. The term BUPRANOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules bupranolol in its Anatomical Therapeutic Chemical (ATC) Classification. BUPRANOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bupranolol under HS 29221980 and SITC 51461. As of Q4 2014, BUPRANOLOL remains the US FDA Preferred Term for this commodity. Bupranolol bears US NLM identifiers UMLS ID C0006403 and NCI Concept Code C72615. SMILES: CLC1C(OCC(O)CNC(C)(C)C)CC(CC1)C.

